MC Stock - Moelis & Company
Unlock GoAI Insights for MC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.19B | $854.75M | $985.30M | $1.54B | $943.28M |
| Gross Profit | $1.19B | $140.00M | $367.10M | $626.70M | $382.47M |
| Gross Margin | 100.0% | 16.4% | 37.3% | 40.7% | 40.5% |
| Operating Income | $172.94M | $-40,352,000 | $216.10M | $495.92M | $265.71M |
| Net Income | $136.02M | $-24,700,000 | $150.34M | $365.21M | $178.83M |
| Net Margin | 11.4% | -2.9% | 15.3% | 23.7% | 19.0% |
| EPS | $1.89 | $-0.36 | $2.29 | $5.79 | $3.16 |
Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. The company offers its services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. The company serves its clients in North and South America, Europe, the Middle East, Asia, and Australia. It has strategic alliances in Mexico with Alfaro, Dávila y Scherer, S.C.; and in Australia with MA Moelis Australia. The company was founded in 2007 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Keefe Bruyette | Downgrade | Market Perform | $80 |
| December 11th 2025 | UBS | Resumed | Neutral | $70 |
| October 30th 2025 | Seaport Research Partners | Upgrade | Buy | $81 |
| October 9th 2025 | Deutsche Bank | Initiation | Buy | $80 |
| October 3rd 2025 | BMO Capital Markets | Initiation | Market Perform | $74 |
| June 23rd 2025 | Morgan Stanley | Upgrade | Overweight | $68 |
| March 13th 2025 | Morgan Stanley | Downgrade | Underweight | $70← $100 |
| December 20th 2024 | Keefe Bruyette | Upgrade | Outperform | $86← $71 |
| December 9th 2024 | Morgan Stanley | Upgrade | Overweight | $92← $66 |
| September 12th 2024 | Wells Fargo | Initiation | Equal Weight | $70 |
| March 13th 2024 | Goldman | Upgrade | Neutral | $58← $53 |
| January 29th 2024 | Keefe Bruyette | Resumed | Market Perform | $56 |
| January 11th 2023 | Goldman | Downgrade | Sell | $37← $40 |
| November 3rd 2022 | Keefe Bruyette | Downgrade | Underperform | $37← $40 |
| September 23rd 2022 | UBS | Downgrade | Sell | $35← $43 |
Earnings History & Surprises
MCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $0.74 | — | — | — |
Q4 2025 | Oct 29, 2025 | $0.57 | $0.68 | +19.3% | ✓ BEAT |
Q3 2025 | Jul 24, 2025 | $0.32 | $0.53 | +65.6% | ✓ BEAT |
Q2 2025 | Apr 23, 2025 | $0.56 | $0.64 | +15.3% | ✓ BEAT |
Q1 2025 | Feb 5, 2025 | $0.39 | $1.18 | +202.6% | ✓ BEAT |
Q4 2024 | Oct 23, 2024 | $0.21 | $0.22 | +4.8% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $0.11 | $0.18 | +63.6% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $0.13 | $0.22 | +69.2% | ✓ BEAT |
Q1 2024 | Feb 7, 2024 | $-0.11 | $-0.06 | +45.5% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.05 | $-0.15 | -400.0% | ✗ MISS |
Q3 2023 | Jul 26, 2023 | $-0.01 | $-0.04 | -255.6% | ✗ MISS |
Q2 2023 | Apr 26, 2023 | $0.10 | $0.05 | -50.0% | ✗ MISS |
Q1 2023 | Feb 8, 2023 | $0.34 | $0.33 | -2.9% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $0.35 | $0.37 | +5.7% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $0.43 | $0.57 | +32.6% | ✓ BEAT |
Q2 2022 | Apr 27, 2022 | $0.77 | $0.95 | +23.4% | ✓ BEAT |
Q1 2022 | Feb 9, 2022 | $1.49 | $1.42 | -4.7% | ✗ MISS |
Q4 2021 | Oct 27, 2021 | $1.35 | $1.77 | +31.1% | ✓ BEAT |
Q3 2021 | Jul 21, 2021 | $0.83 | $1.19 | +43.4% | ✓ BEAT |
Latest News
Keefe, Bruyette & Woods Downgrades Moelis to Market Perform, Raises Price Target to $80
➖ NeutralKeefe, Bruyette & Woods Maintains Outperform on Moelis, Lowers Price Target to $78
➖ NeutralMoelis Q3 Adj. EPS $0.68 Beats $0.57 Estimate, Sales $375.984M Beat $356.924M Estimate
📈 PositiveKeefe, Bruyette & Woods Maintains Outperform on Moelis, Lowers Price Target to $80
➖ NeutralBMO Capital Initiates Coverage On Moelis with Market Perform Rating, Announces Price Target of $74
➖ NeutralMorgan Stanley Maintains Overweight on Moelis, Raises Price Target to $90
📈 PositiveFrequently Asked Questions about MC
What is MC's current stock price?
What is the analyst price target for MC?
What sector is Moelis & Company in?
What is MC's market cap?
Does MC pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to MC for comparison